These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6328990)

  • 1. Changes in cerebral blood flow in patients with severe congestive cardiac failure before and after captopril treatment.
    Rajagopalan B; Raine AE; Cooper R; Ledingham JG
    Am J Med; 1984 May; 76(5B):86-90. PubMed ID: 6328990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral blood flow in patients with congestive heart failure treated with captopril.
    Paulson OB; Jarden JO; Godtfredsen J; Vorstrup S
    Am J Med; 1984 May; 76(5B):91-5. PubMed ID: 6328991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of captopril on cerebral blood flow in normotensive and hypertensive rats.
    Barry DI; Paulson OB; Jarden JO; Juhler M; Graham DI; Strandgaard S
    Am J Med; 1984 May; 76(5B):79-85. PubMed ID: 6328989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and regional blood flow response to captopril in congestive heart failure.
    Levine TB; Olivari MT; Cohn JN
    Am J Med; 1984 May; 76(5B):38-42. PubMed ID: 6375361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
    Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
    Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of captopril on the cerebral circulation in chronic heart failure.
    Paulson OB; Jarden JO; Vorstrup S; Holm S; Godtfredsen J
    Eur J Clin Invest; 1986 Apr; 16(2):124-32. PubMed ID: 3089807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrovascular aspects of converting-enzyme inhibition II: Blood-brain barrier permeability and effect of intracerebroventricular administration of captopril.
    Jarden JO; Barry DI; Juhler M; Graham DI; Strandgaard S; Paulson OB
    J Hypertens; 1984 Dec; 2(6):599-604. PubMed ID: 6098609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
    Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK
    N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
    Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
    Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme.
    Davis R; Ribner HS; Keung E; Sonnenblick EH; LeJemtel TH
    N Engl J Med; 1979 Jul; 301(3):117-21. PubMed ID: 221810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure.
    Awan NA; Evenson MK; Needham KE; Win A; Mason DT
    Am Heart J; 1981 Jan; 101(1):22-31. PubMed ID: 6257100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders.
    Packer M; Medina N; Yushak M
    Am J Cardiol; 1984 Oct; 54(7):771-7. PubMed ID: 6091434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.
    Levine TB; Franciosa JA; Cohn JN
    Circulation; 1980 Jul; 62(1):35-41. PubMed ID: 6247102
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
    Creager MA; Faxon DP; Weiner DA; Ryan TJ
    Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined vasodilator therapy for chronic congestive heart failure.
    Cody RJ; Franklin KW; Laragh JH
    Am Heart J; 1983 Apr; 105(4):575-80. PubMed ID: 6340448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of chronic congestive heart-failure by oral captopril.
    Turini GA; Brunner HR; Gribic M; Waeber B; Gavras H
    Lancet; 1979 Jun; 1(8128):1213-5. PubMed ID: 87679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.
    Townend JN; Doran J; Lote CJ; Davies MK
    Br Heart J; 1995 May; 73(5):434-41. PubMed ID: 7786658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of converting enzyme inhibitor on hepatic blood flow in man.
    Crossley IR; Bihari D; Gimson AE; Westaby D; Richardson PJ; Williams R
    Am J Med; 1984 May; 76(5B):62-5. PubMed ID: 6328986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme].
    Komajda M; Eugène M; Evans J; Laurenceau JL; Hubermann JP; Thomas D; Drobinski G; Leprince JL; Ganty J; Wajman A; Guedj D; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril in congestive heart failure.
    Liebau G; Riegger AJ; Schanzenbächer P; Steilner H; Oehrlein S
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):193S-199S. PubMed ID: 6753901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.